Details for New Drug Application (NDA): 205869
✉ Email this page to a colleague
The generic ingredient in LETROZOLE is letrozole. There are twenty-four drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the letrozole profile page.
Summary for 205869
Tradename: | LETROZOLE |
Applicant: | Beijing Yiling |
Ingredient: | letrozole |
Patents: | 0 |
Pharmacology for NDA: 205869
Mechanism of Action | Aromatase Inhibitors |
Suppliers and Packaging for NDA: 205869
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LETROZOLE | letrozole | TABLET;ORAL | 205869 | ANDA | Avet Pharmaceuticals Inc. | 23155-875 | 23155-875-03 | 30 TABLET, FILM COATED in 1 BOTTLE (23155-875-03) |
LETROZOLE | letrozole | TABLET;ORAL | 205869 | ANDA | Avet Pharmaceuticals Inc. | 23155-875 | 23155-875-09 | 90 TABLET, FILM COATED in 1 BOTTLE (23155-875-09) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Nov 14, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription